ENLARGEMENT OF CEREBRAL 3RD VENTRICLE IN PSYCHOTIC-PATIENTS WITH DELAYED-RESPONSE TO NEUROLEPTICS

Enlargement of the cerebral third ventricle appears to be a replicable finding in groups of patients with psychotic illnesses, and there is evidence for an association of third ventricle enlargement with poorer response to treatment. Third ventricle area and width were measured from computed tomography (CT) scans in 24 mood-incongruent psychotic patients and 14 controls age and gender matched to schizophrenic patients. Patients were treated with a fixed dose of haloperidol and classified as rapid responders (55% symptom reduction on New Haven Schizophrenic Index (NHSI) within 4.5 ± 1.3days or delayed responders (55% symptom reduction on NHSI within 18.6 ± 10.5 days. The significant enlargement of third ventricle area was isolated among the 12 delayed neuroleptic responders (19.3 ± 9.0 mm2) compared with the 14 controls (11.7 ± 4.8 mm2, p = 0.01), and 12 other mood-incongruent psychotics. Third ventricle width also showed a trent towards larger width in the delayed responders. There was a clear positive correlation between ventricular size and patient's age exclusively in the delayed responders (r = 0.78); a comparable relationship between ventricular size and age was not present in controls, or in the other psychotics. This finding is consistent with an age-related progressive degenerative process in the central nervous system (CNS) isolated to the neuroleptic-delayed responsive psychotics. © 1990.